Fetal growth, preeclampsia, and adult breast cancer risk;Fostervekst, preeklampsi og fremtidig brystkreftrisiko

Tidsskrift for den Norske Laegeforening

Volumn 122, Issue 26, 2002, Pages 2525-2529

  Nilsen, Tom Ivar Lund ^a   Vatten, Lars J ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN;

ARTICLE; BIRTH WEIGHT; BREAST CANCER; CANCER RISK; DIZYGOTIC TWINS; FETUS GROWTH; GROWTH RATE; MONOZYGOTIC TWINS; PREECLAMPSIA; RISK ASSESSMENT;

ADULT; BIRTH WEIGHT; BREAST NEOPLASMS; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; HUMANS; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY, MULTIPLE; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; TWINS;

EID: 0037202236     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Trichopoulos D. Does breast cancer originate in utero? Lancet 1990; 335: 939-40.
2. Potischman N, Troisi R. In-utero and early exposures in relation to risk of breast cancer. Cancer Causes Control 1999; 10: 561-73.
3. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal influences on breast cancer risk. Lancet 1992; 340: 1015-8.
4. Ekbom A, Hsieh CC, Lipworth L, Adami HO, Trichopoulos D. Intrauterine environment and breast cancer risk in women: A population-based study. J Natl Cancer Inst 1997; 89: 71-6.
5. Michels KB, Trichopoulos D, Robins JM, Rosner BA, Manson JE, Hunter DJ et al. Birthweight as a risk factor for breast cancer. Lancet 1996; 348: 1542-6.
6. Le Marchand L, Kolonel LN, Myers BC, Mi M-P. Birth characteristics of premenopausal women with breast cancer. Br J Cancer 1988; 57: 437-9.
7. Sanderson M, Williams MA, Malone KE, Stanford JL, Emanuel I, White E et al. Perinatal factors and risk of breast cancer. Epidemiology 1996; 7: 34-7.
8. Sanderson M, Shu XO, Jin F, Dai Q, Ruan Z, Gao Y-T et al. Weight at birth and adolescence and premenopausal breast cancer in a low-risk population. Br J Cancer 2002; 86: 84-8.
9. Sanderson M, Williams MA, Malone KE, Stanford JL, Emanuel I, White E et al. Perinatal factors and risk of breast cancer. Br J Cancer 1998; 57: 437-9.
10. Innes K, Byers T, Schymura M. Birth characteristics and subsequent risk for breast cancer in very young women. Am J Epidemiol 2000; 152: 1121-8.
11. Stavola BL, Hardy R, Kuh D, Silva IS, Wadsworth M, Swerdlow AJ. Birthweight, childhood growth and risk of breast cancer in a British cohort. Br J Cancer 2000; 83: 964-8.
12. Kajser M, Lichtenstein P, Granath F, Erlandsson G, Cnattingius S, Ekbom A. In utero exposures and breast cancer: A study of opposite-sexed twins. J Natl Cancer Inst 2001; 93: 60-2.
13. Hübinette A, Lichtenstein P, Ekbom A, Cnattingius S. Birth characteristics and breast cancer risk: A study among like-sexed twins. Int J Cancer 2001; 91: 248-51.
14. Vatten LJ, Mæhle BO, Nilsen TIL, Tretli S, Hsieh CC, Trichopoulos D et al. Birth weight as a predictor of breast cancer: A case-control study in Norway. Br J Cancer 2002; 86: 89-91.
15. Mazor M, Hershkovitz R, Chaim W, Levy J, Sharony Y, Leiberman JR et al. Human preterm birth is associated with systemic and local changes in progesterone/17 beta-estradiol ratios. Am J Obstet Gynecol 1994; 171: 231-6.
16. Robine N, Relier JP, Le Bars S. Urocytogram, an index of maturity in premature infants. Biol Neonate 1988; 54: 93-9.
17. Sedin G, Bergquist C, Lindgren PG. Ovarian hyperstimulation syndrome in preterm infants. Pediatr Res 1985; 19: 548-52.
18. Ekbom A, Erlandsson G, Hsieh CC, Trichopoulos D, Adami HO, Cnattingius S. Risk of breast cancer in prematurely born women. J Natl Cancer Inst 2000; 92: 840-1.
19. Ekbom A, Thurfjell E, Hsieh CC, Trichopoulos D, Adami H-O. Perinatal characteristics and adult mammographic patterns. Int J Cancer 1995; 61: 177-80.
20. Hsieh CC, Lan SJ, Ekbom A, Petridou E, Adami HO, Trichopoulos D. Twin membership and breast cancer risk. Am J Epidemiol 1992; 136: 1321-6.
21. Verkasalo PK, Kaprio J, Pukkala E, Koskenvuo M. Breast cancer risk in monozygotic and dizygotic female twins: A 20-year population-based cohort study in Finland from 1976 to 1995. Cancer Epidemiol Biomarkers Prev 1999; 8: 271-4.
22. Cerhan JR, Kushi LH, Olson JE, Rich SS, Zheng W, Folsom AR et al. Twinship and risk of postmenopausal breast cancer. J Natl Cancer Inst 2000; 92: 261-5.
23. Weiss HA, Potischman NA, Brinton LA, Brogan D, Coates RJ, Gammon MD et al. Prenatal and perinatal risk factors for breast cancer in young women. Epidemiology 1997; 8: 181-7.
24. Titus-Emstoff L, Newcomb PA, Egan KM, Baron JA, Greenberg ER, Trichopoulos D et al. Left-handedness in relation to breast cancer risk in postmenopausal women. Epidemiology 2000; 11: 181-4.
25. Yuen J, Ekbom A, Trichopoulos D, Hsieh CC, Adami HO. Season of birth and breast cancer risk in Sweden. Br J Cancer 1994; 70: 564-8.
26. Lipworth L, Hsieh CC, Wide L, Ekbom A, Yu SZ, Yu GP et al. Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer 1999; 79: 7-12.
27. Roberts J, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001; 357: 53-6.
28. Ødegård RA, Vatten LJ, Nilsen ST, Salvesen KÅ, Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol 2000; 96: 950-5.
29. Melbye M, Wohlfart J, Lei U, Norgaard-Pedersen B, Mouridsen HT, Lambe M et al. α-feto-protein levels in maternal serum during pregnancy and maternal breast cancer incidence. J Natl Cancer Inst 2000; 92: 1001-5.
30. Richardson BE, Hulka BS, Peck JL, Hughes CL, van den Berg BJ, Christianson RE et al. Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. Am J Epidemiol 1998; 148: 719-27.
31. Jacobson HI, Bennett JA, Mizejewski GJ. Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol. Cancer Res 1990; 50: 415-20.
32. Bennet JA, Zhu S, Pagano-Mirarchi A, Kellom TA, Jacobson HI. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts. Clin Cancer Res 1998; 4: 2877-84.
33. Vakharia D, Mizejewski GJ. Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer. Breast Cancer Res Treat 2000; 63: 41-52.
34. Vatten LJ, Ødegård RA, Nilsen ST, Salvesen KA, Austgulen R. Insulin-like growth factor-I and IGF binding proteins in umbilical cord plasma in relation to preeclampsia and infant birth weight: A prospective study in Norway. Obstet Gynecol 2002; 99: 85-90.
35. Vatten LJ, Romundstad PR, Odegard RA, Nilsen ST, Trichopoulos D, Austgulen R. Alphafoetoprotein in umbilical cord in relation to severe pre-eclampsia, birth weight and future breast cancer risk. Br J Cancer 2002; 86: 728-31.
36. Giudice LC, Martina NA, Crystal RA, Tazuke S, Druzin M. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol 1997; 176: 751-8.
37. Hankinson S, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B et al. Circulating concentrations of insulin-like growth factor I and risk of breast cancer. Lancet 1998; 351: 1393-6.